MetaCap

ImmuCell Statistics

NASDAQ: ICCCHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

10.92-0.27 (-2.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ImmuCell by the numbers

ImmuCell has a market capitalization of $99.3 million based on 9.09M shares outstanding. Its trailing P/E ratio is 57.5. The stock trades 6.7% above its 50-day average and 18.9% above its 200-day average.

Average daily trading volume is 13.44K shares, or about $146,798 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ICCC valuation vs. peer median

ICCC compared with the median of 8 peer companies
MetricICCCPeer medianDifference
Market cap$99.28M$5.02M+1877%
Avg. volume13.44K195.12K-93%

Peer median across 8 companies: IMDX, NNNN, VNRX, TRIB, BMRA, CDIO, QCLS, VRAX.

Valuation

Market cap
$99.28M
Price / sales (latest FY)
3.59

Price and trading

Previous close
11.19
Open
11.06
Day range
10.31 – 11.25
52-week range
4.67 – 12.10
52-week change
+133.33%
Beta
—
Volume
18.75K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
99.28M
Pe
57.47
Forward Pe
-99.27
Eps
0.19
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
12.10
Week52 Low
4.67
Avg Volume
13,443.00
Shares Outstanding
9.09M
Ma50
10.24
Ma200
9.18
Earnings Date
Nov 12, 2026
Pct From52w High
-9.75%
Pct From52w Low
133.83%

Related